Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation

NCT04180059 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Haematologic Disease

Interventions

COMBINATION_PRODUCT: CTL 19

Sponsor

Nantes University Hospital

Collaborators

[object Object]